Biofortis, Merieux NutriSciences
Global clinical and bioanalytical laboratory services organization providing central laboratory testing, bioanalytical and ADME assays, biomarker and assay development, genomics, digital pathology and sample-tracking technologies to support drug discovery and development across preclinical and clinical stages.
Industries
N/A
Nr. of Employees
small (1-50)
Biofortis, Merieux NutriSciences
Products
Electronic e‑requisition and site lab navigator
E‑requisition workflow to streamline sample ordering and improve data quality between investigator sites and laboratory services.
AI-driven instant insights for biospecimen and clinical operations
Natural‑language analytics that generate automated visualizations and operational insights from biospecimen and clinical trial data.
Electronic e‑requisition and site lab navigator
E‑requisition workflow to streamline sample ordering and improve data quality between investigator sites and laboratory services.
AI-driven instant insights for biospecimen and clinical operations
Natural‑language analytics that generate automated visualizations and operational insights from biospecimen and clinical trial data.
Services
Comprehensive central laboratory testing and sample management for multi‑site clinical trials worldwide.
Quantitative LC‑MS, immunoassay, hybrid methods and in vitro ADME services supporting discovery through regulatory submission.
Genomic testing and sequencing for translational and clinical research, including RNA‑seq, HLA calling and ultra‑deep sequencing workflows.
Custom biomarker and vaccine assay design, fit‑for‑purpose validation and technology transfer into clinical trial workflows.
Vaccine-specific assay development and testing including neutralization and high‑throughput vaccine testing.
Web-based platform for biospecimen tracking, reconciliation, reporting and computable consent management across distributed trial ecosystems.
Comprehensive central laboratory testing and sample management for multi‑site clinical trials worldwide.
Quantitative LC‑MS, immunoassay, hybrid methods and in vitro ADME services supporting discovery through regulatory submission.
Genomic testing and sequencing for translational and clinical research, including RNA‑seq, HLA calling and ultra‑deep sequencing workflows.
Custom biomarker and vaccine assay design, fit‑for‑purpose validation and technology transfer into clinical trial workflows.
Vaccine-specific assay development and testing including neutralization and high‑throughput vaccine testing.
Web-based platform for biospecimen tracking, reconciliation, reporting and computable consent management across distributed trial ecosystems.
Expertise Areas
- Central laboratory management for clinical trials
- Bioanalytical and ADME testing
- Biomarker assay development and validation
- Genomics and RNA sequencing for clinical research
Key Technologies
- Next-generation sequencing (NGS)
- RNA sequencing (RNA‑Seq, mRNA‑Seq)
- Ultra‑deep sequencing
- TCR/BCR repertoire sequencing
News & Updates
Conference focused on operational strategies for clinical trials; laboratory participation and meeting scheduling available.
Industry conference for vaccine development where laboratory scientists present methods and data.
White paper describing mRNA sequencing assay approaches for clinical and translational research.
Factsheet on implementing ultra‑deep sequencing workflows to increase sensitivity while managing cost.
Poster describing the role of LC‑MS in DMPK studies for peptide therapeutics presented at ObesityWeek 2025.
Poster on feasibility of a multiplexed immunogenicity assay presented at WRIB 2026.
Conference focused on operational strategies for clinical trials; laboratory participation and meeting scheduling available.
Industry conference for vaccine development where laboratory scientists present methods and data.
White paper describing mRNA sequencing assay approaches for clinical and translational research.
Factsheet on implementing ultra‑deep sequencing workflows to increase sensitivity while managing cost.
Poster describing the role of LC‑MS in DMPK studies for peptide therapeutics presented at ObesityWeek 2025.
Poster on feasibility of a multiplexed immunogenicity assay presented at WRIB 2026.